Table 1: Baseline characteristics stratiﬁed by presence of vertebral fracture. No vertebral fracture Vertebral fracture Table 2: BMD and FRAX stratiﬁed by presence of vertebral fracture. No vertebral fracture Vertebral fracture Table 3: Summary of multiple regression analysis for variables predicting spine bone mineral density. Variable PSA∗ Age Model 1 B (SE) 0.02 (0.01) — P 0.03 — Model 2 B (SE) 0.02 (0.01) 0.005 (0.003) P 0.05 0.08 Model 3 B (SE) 0.02 (0.01) 0.005 (0.003) P 0.05 0.04 Model 4 B (SE) 0.02 (0.01) 0.004 (0.002) P 0.045 0.12 Model 5 B (SE) 0.02 (0.01) 0.004 (0.002) P 0.05 0.13 Model 6 B (SE) 0.02 (0.01) 0.004 (0.003) P 0.04 0.04 B = regression coeﬃcient, SE = standard error. ∗loge transformed PSA. Race is modeled as African-American versus non-African-American. Weight — — — — 0.0007 (0.0005) 0.17 — — — — 0.0004 (0.0005) 0.40 Vitamin D supplement — — — — — — −0.13 (0.04) 0.001 −0.12 (0.04) 0.001 −0.12 (0.04) 0.003 n = 56 Median 16.5 77.0 83.5 172.7 5.1 28.4 31.1 9.7 44.0 80.0 0.3 0.1 Mean 39.6 76.5 84.8 171.7 5.8 28.5 30.3 9.5 49.5 92.4 6.2 0.6 SD 44.7 8.2 17.1 6.1 3.0 4.9 14.6 1.3 28.1 80.6 15.1 1.3 Range 0.0–10.5 58.0–77.5 54.5–86.7 152.4–171.4 0.8–5.8 18.2–28.6 7.0–26.1 0.7–9.6 16.7–37.3 49.0–73.0 0.1–0.3 0.1–0.2 Mean 0.7 −1.9 0.9 −1.3 1.0 −0.9 10.8 5.5 9.5 4.5 SD 0.1 0.7 0.1 0.9 0.2 1.6 6.2 4.8 6.9 5.1 Range 0.5–1.0 −3.3–−0.7 0.6–1.2 −3.0–0.3 0.8–1.6 −4.0–4.6 1.8–33.0 0.1–24.0 1.9–33.0 0.1–28.0 n = 22 Median 10.5 77.5 86.7 171.4 5.8 28.6 26.1 9.6 37.3 73.0 0.3 0.2 n = 22 Median 0.7 −2.2 0.8 −1.4 0.9 −1.8 15.0 6.8 11.0 4.5 Mean 30.3 78.0 87.1 172.5 6.4 28.7 27.1 9.5 45.9 74.2 2.8 1.4 Mean 0.7 −2.0 0.8 −1.5 0.9 −1.6 16.0 8.1 14.0 6.6 SD 43.5 6.7 18.0 7.1 3.6 5.5 10.9 0.5 28.8 17.0 6.7 1.7 SD 0.1 0.8 0.2 1.1 0.2 1.8 6.8 6.0 7.8 7.1 Journal of Osteoporosis Variable Duration of ADT (months) Age (years) Weight (kg) Height (cm) Height loss (cm) BMI (kg/m2) 25-(OH) Vitamin D (ng/mL) Serum calcium (mg/dL) Parathyroid hormone (pg/mL) Alkaline phosphatase (U/L) Prostate-speciﬁc antigen (PSA) (ng/mL) Testosterone (ng/mL) ∗ P values are from the Wilcoxon rank sum test. n = 56 Variable Median BMD, femoral neck 0.7 T score, femoral neck −1.8 BMD, total hip 0.9 T score, total hip −1.2 BMD, lumbar spine 1.0 T score, lumbar spine −1.1 FRAX (Osteo) without BMD (%) 9.3 FRAX (Hip) without BMD (%) 4.0 FRAX (Osteo) with BMD (%) 7.5 FRAX (Hip) with BMD (%) 3.0 ∗ P values are from the Wilcoxon rank sum test. BMD measurements are in g/cm2. Range 0.0–156.0 63.0–88.0 54.8–119.8 157.5–182.9 1.3–14.0 18.3–40.4 8.0–57.8 7.9–10.6 15.8–135.0 47.0–112.0 0.1–30.7 0.1–5.9 Range 0.5–0.9 −3.4–−0.6 0.5–1.2 −3.7–0.0 0.5–1.3 −5.2–2.1 6.8–31.0 1.7–25.0 5.4–41.0 1.1–36.0 Race — — — — — — — — 0.04 (0.04) 0.33 — — 3 P value∗ 0.21 0.53 0.46 0.83 0.58 0.76 0.42 0.52 0.49 0.16 0.49 0.01 P-value∗ 0.34 0.33 0.22 0.51 0.11 0.10 0.001 0.03 0.002 0.03 R2 0.06 0.08 0.09 0.22 0.23 0.23